BY THE DIGITAL HEALTH LEADERS FOR THE DIGITAL HEALTH COMMUNITY
BY THE DIGITAL HEALTH LEADERS 
ENTOD Pharma Appoints Dharmesh Kharwar as Non-Executive Independent Director October 18, 2024
USV Introduces Heart Failure Medication “OnArni’’ October 17, 2024 USV launched the affordable heart failure drug OnArni at INR 8 per tablet, aiming to ease the financial burden on patients managing the condition.
India Leads Global Vaccine Production: Health Secretary October 16, 2024 Union Health Secretary Punya Salila Srivastava highlighted that half of the 8 billion vaccines produced last year came from India.
India's Drug Regulatory Process 95% Digitised: Health Minister October 15, 2024 Union Health Minister JP Nadda announced 95% digitisation of India's drug regulatory processes, boosting transparency and efficiency in drug approvals and quality control.
City Imaging & Clinical Labs Expands Services Across North India October 15, 2024 City Imaging & Clinical Labs plans to expand its diagnostic services across North India. It aims to partner with 50+ hospitals to enhance patient care through high-quality lab management and diagnostic tools.
Indian Pharmacopoeia Standard Recognized by 11 Countries: DCGI Rajeev Raghuvanshi October 15, 2024 India's pharmacopoeia standard is now recognized by 11 countries, with India playing a pivotal role in global drug, vaccine, and medical device supply, says DCGI Rajeev Raghuvanshi.
K’taka Seeks Investment from US Life Sciences Cos to Boost Pharma & Biotech Sectors October 15, 2024 Karnataka is actively courting investments from US-based life sciences companies to strengthen its pharmaceutical and biotechnology industries.
DCGI Refutes Claims of Labeling Drugs as Spurious, Calls Reports Misinterpretation October 10, 2024 DCGI clarifies reports of spurious drugs, stating only five out of 50 drugs flagged were spurious, while the others were not up to standard. Routine checks ensure drug safety, says DCGI.
ChrysCapital to Acquire 20% Stake in HealthKart, Valuing the Company at $450 Mn October 9, 2024 ChrysCapital is acquiring a 20% stake in HealthKart's parent, Bright Lifecare, valuing the company at $450M (INR 3,700 Cr), with the deal expected to close soon.
AstraZeneca to License Cardiovascular Drug from CSPC Pharma for a Whopping $2 Bn October 8, 2024 AstraZeneca signs a deal with CSPC Pharmaceutical Group, agreeing to pay up to $2 billion to license a cardiovascular drug aimed at treating dyslipidaemia.
Agilus Diagnostics Launches Pharmacogenomics Testing Service October 8, 2024 Agilus Diagnostics has launched its Pharmacogenomics Testing Service, which aims to help healthcare providers personalize treatments by understanding how a patient’s genetic makeup affects their response to medications.
Enzene Introduces New Continuous Manufacturing Tech for Biologics October 8, 2024 Enzene unveils its new EnzeneX 2.0 platform, a continuous manufacturing system for biologics, at CPHI Milan 2024. The platform enhances productivity, reduces costs, and streamlines production processes.
